GI
GelMEDIX, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$747Ksold at filing
Total offering$2.5M$1.8M still open
Investors in the raise5count reported to the SEC
FiledApr 30, 2026first sale Oct 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Nasim AnnabiDirector
Michael CimaDirector
Reza DanaDirector
Parinaz MotamedyDirector
Max CotlerExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.